What Devices Need ASCA Testing for FDA Submissions?

A device does not need ASCA testing solely because it is a medical device or because it will be submitted to the FDA. The more useful question is what devices need ASCA testing when their FDA submission relies on conformity to an FDA-recognized consensus standard within the ASCA program scope. For those devices, testing through an FDA ASCA-accredited laboratory can provide a more direct path to demonstrating compliance with applicable safety and performance requirements.

ASCA, or the Accreditation Scheme for Conformity Assessment, is an FDA program for selected medical device testing standards. It recognizes accredited testing laboratories that have demonstrated competence to perform testing to specific standards. When an eligible device is tested by an ASCA-accredited laboratory within that laboratory’s accredited scope, the manufacturer may submit a declaration of conformity supported by ASCA documentation as part of its premarket submission.

ASCA Testing Is Not Based on Device Class Alone

There is no fixed list that says all Class II devices, all monitors, or all ultrasound systems require ASCA testing. Eligibility depends on the device, its intended use, the FDA-recognized standard being cited, and whether that standard is currently included in the ASCA program. The laboratory must also hold ASCA accreditation for the exact standard and testing scope needed.

In practice, ASCA is most relevant to electrically powered medical devices that need evidence of conformity to safety and electromagnetic compatibility standards. This often includes devices governed by the IEC 60601 family of standards, along with applicable particular and collateral standards. Examples may include patient monitors, electrocardiographs, diagnostic ultrasound equipment, physiotherapy systems, powered diagnostic equipment, and certain active therapeutic devices.

The device category alone is not enough. A patient monitor, for example, may require evaluation to IEC 60601-1 for basic safety and essential performance and IEC 60601-1-2 for electromagnetic disturbances. Depending on its functions, accessories, and intended clinical environment, additional particular standards may apply. The ASCA question must be assessed at the standard level, not simply at the product-label level.

What Devices Need ASCA Testing Most Often?

Manufacturers should consider ASCA testing when their device has an applicable FDA-recognized standard that falls within an ASCA-accredited laboratory’s scope. The strongest use case is a premarket submission where electrical safety, EMC, or another covered test area is necessary to support a declaration of conformity.

Devices commonly evaluated under these types of standards include:

• Diagnostic and monitoring equipment, such as ECG systems, multiparameter monitors, and vital-signs devices.
• Diagnostic ultrasound systems and ultrasound transducers, where electrical safety, essential performance, acoustic output, and image-quality considerations may all be relevant.
• Active therapeutic and physiotherapy equipment, including devices that deliver electrical, ultrasonic, thermal, or other forms of energy.
• Powered endoscopic and accessory systems that incorporate electrical equipment, imaging functions, illumination, or patient-connected components.
• Laboratory and clinical instruments that are medical electrical equipment and must demonstrate safe operation in their intended use environment.

These examples are not automatic ASCA candidates. A device may require electrical safety or EMC testing but still fall outside the current ASCA scope for a particular standard. Conversely, a device with a less obvious electrical risk profile may be an ASCA candidate if it relies on an in-scope recognized standard. The current FDA recognition status and the laboratory’s accreditation scope should be confirmed before the test plan is finalized.

The Standards Drive the Testing Strategy

For many active medical devices, IEC 60601-1 is the starting point. It addresses basic safety and essential performance, including protection against electrical hazards, mechanical hazards, excessive temperatures, fire, and other reasonably foreseeable risks. Testing can include dielectric strength, leakage current, protective earth continuity, temperature measurement, mechanical stability, and review of means of patient protection.

IEC 60601-1-2 addresses electromagnetic compatibility. It evaluates whether the device can operate as intended in the presence of electromagnetic disturbances and whether its emissions are controlled. Immunity testing may assess performance during electrostatic discharge, radiated radio-frequency fields, electrical fast transients, surge events, and voltage interruptions. Emissions testing evaluates conducted and radiated emissions that could affect other equipment.

Particular standards add device-specific requirements. An ultrasound system, for example, may have requirements beyond general electrical safety and EMC. Its submission strategy may also need acoustic output characterization, transducer performance evaluation, image-quality testing, and verification of system controls. An ECG device may require consideration of patient leads, defibrillation protection, signal performance, alarms, and the applicable particular standard.

ASCA testing does not replace engineering judgment or risk management. It is one component of an evidence package. The testing program still needs to align with the device’s intended use, accessories, configurations, software-controlled functions, clinical environment, and risk controls documented in the design history file.

When ASCA May Be Preferable to Conventional Testing

Testing at an ASCA-accredited laboratory can be particularly valuable when a manufacturer expects to submit a declaration of conformity to an eligible FDA-recognized standard. The ASCA framework gives FDA added confidence that the laboratory’s methods, personnel, equipment, and quality system have been assessed for the applicable testing scope.

For regulatory teams, the practical benefit is not that ASCA lowers the technical bar. The device must still meet the standard’s acceptance criteria. The benefit is a clearer conformity-assessment pathway and documentation designed for FDA reliance when the submission and test scope qualify.

That distinction matters during project planning. A complete report from an ISO/IEC 17025-accredited laboratory may be appropriate for many programs, including standards not covered by ASCA, international market requirements, exploratory engineering work, or product families with unusual configurations. ASCA is most useful when the FDA submission specifically benefits from it and the applicable standard is available under the program.

Questions to Resolve Before Scheduling Testing

The best time to determine ASCA applicability is before formal verification testing begins. Late changes to a power supply, enclosure, patient cable, wireless module, software function, or accessory can affect electrical safety and EMC results. They can also create uncertainty about whether the tested configuration represents the commercial device.

First, identify the likely FDA product code and submission pathway. Then review the FDA-recognized consensus standards associated with the device type and determine which standards will support the declaration of conformity. This review should account for the edition of each standard, amendments, deviations, and transition dates recognized by FDA.

Next, define the worst-case test configuration. For electrical safety, this may be the configuration with the highest mains voltage, greatest power consumption, most demanding patient connection, or highest accessible temperature. For EMC, it may be the configuration with active wireless functions, longest cables, the most sensitive operating mode, or the highest emissions profile. A poorly selected configuration can produce a report that does not adequately support the final marketed device.

Finally, confirm the laboratory scope rather than assuming program-level accreditation covers every test. Sigma Scientific Services can help manufacturers align device configurations and required evidence with applicable electrical, acoustic, ultrasound, and performance testing needs, subject to the specific accreditation scope and standard requested.

ASCA Documentation Must Match the Submission

An ASCA-supported submission depends on consistency. The device name, model numbers, accessories, software version, standards edition, test configuration, deviations, and declarations must align across the laboratory documentation and the FDA submission. Small administrative mismatches can create avoidable regulatory questions, particularly when a product line contains several similar configurations.

Manufacturers should also distinguish between a test failure, a deviation, and an unresolved design question. A failure requires corrective action and retesting. A permitted standard deviation must be clearly understood and appropriately addressed in the regulatory rationale. An unresolved question about intended use or essential performance should be settled before the laboratory begins final testing, because it may change the applicable standard or acceptance criteria.

The most efficient ASCA strategy is therefore not to ask whether a device is generally eligible. Start with the final commercial configuration, the FDA-recognized standards needed for the submission, and the evidence each standard requires. That approach gives the testing laboratory a defined target and gives the regulatory team a defensible basis for deciding whether ASCA is the right conformity-assessment route.